|
1
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2021. CA Cancer J Clin. 71:7–33. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kalnins IK, Leonard AG, Sako K, Razack MS
and Shedd DP: Correlation between prognosis and degree of lymph
node involvement in carcinoma of the oral cavity. Am J Surg.
134:450–454. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schuller DE, McGuirt WF, McCabe BF and
Young D: The prognostic significance of metastatic cervical lymph
nodes. Laryngoscope. 90:557–570. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Snow GB, Annyas AA, van Slooten EA,
Bartelink H and Hart AA: Prognostic factors of neck node
metastasis. Clin Otolaryngol Allied Sci. 7:185–192. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Grandi C, Alloisio M, Moglia D, Podrecca
S, Sala L, Salvatori P and Molinari R: Prognostic significance of
lymphatic spread in head and neck carcinomas: Therapeutic
implications. Head Neck Surg. 8:67–73. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chi AC, Day TA and Neville BW: Oral cavity
and oropharyngeal squamous cell carcinoma-an update. CA Cancer J
Clin. 65:401–421. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sano D and Myers JN: Metastasis of
squamous cell carcinoma of the oral tongue. Cancer Metastasis Rev.
26:645–662. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ho CM, Lam KH, Wei WI, Lau SK and Lam LK:
Occult lymph node metastasis in small oral tongue cancers. Head
Neck. 14:359–363. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Myers EN and Simental AA Jr: Cancer of the
oral cavity. Cancer of the Head and Neck. 4th edition. Myers EN,
Suen JY, Myers JN and Hanna EY: Saunders; Philadelphia, PA: pp.
279–319. 2003
|
|
10
|
Teichgraeber JF and Clairmont AA: The
incidence of occult metastases for cancer of the oral tongue and
floor of the mouth: Treatment rationale. Head Neck Surg. 7:15–21.
1984. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cunningham MJ, Johnson JT, Myers EN,
Schramm VL Jr and Thearle PB: Cervical lymph node metastasis after
local excision of early squamous cell carcinoma of the oral cavity.
Am J Surg. 152:361–366. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fakih AR, Rao RS and Patel AR:
Prophylactic neck dissection in squamous cell carcinoma of oral
tongue: A prospective randomized study. Semin Surg Oncol.
5:327–330. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lydiatt DD, Robbins KT, Byers RM and Wolf
PF: Treatment of stage I and II oral tongue cancer. Head Neck.
15:308–312. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yuen AP, Wei WI, Wong YM and Tang KC:
Elective neck dissection versus observation in the treatment of
early oral tongue carcinoma. Head Neck. 19:583–588. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yuen AP, Lam KY, Chan AC, Wei WI, Lam LK,
Ho WK and Ho CM: Clinicopathological analysis of elective neck
dissection for N0 neck of early oral tongue carcinoma. Am J Surg.
177:90–92. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Müller S, Pan Y, Li R and Chi AC: Changing
trends in oral squamous cell carcinoma with particular reference to
young patients: 1971-2006. The Emory University experience. Head
Neck Pathol. 2:60–66. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Patel SC, Carpenter WR, Tyree S, Couch ME,
Weissler M, Hackman T, Hayes DN, Shores C and Chera BS: Increasing
incidence of oral tongue squamous cell carcinoma in young white
women, age 18 to 44 years. J Clin Oncol. 29:1488–1494. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Toporcov TN, Znaor A, Zhang ZF, Yu GP,
Winn DM, Wei Q, Vilensky M, Vaughan T, Thomson P, Talamini R, et
al: Risk factors for head and neck cancer in young adults: A pooled
analysis in the INHANCE consortium. Int J Epidemiol. 44:169–185.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Santulli G: Angiopoietin-like proteins: A
comprehensive look. Front Endocrinol (Lausanne). 5:42014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang RL, Teo Z, Chong HC, Zhu P, Tan MJ,
Tan CK, Lam CR, Sng MK, Leong DT, Tan SM, et al: ANGPTL4 modulates
vascular junction integrity by integrin signaling and disruption of
intercellular VE-cadherin and claudin-5 clusters. Blood.
118:3990–4002. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li H, Ge C, Zhao F, Yan M, Hu C, Jia D,
Tian H, Zhu M, Chen T, Jiang G, et al: Hypoxia-inducible factor 1
alpha-activated angiopoietin-like protein 4 contributes to tumor
metastasis via vascular cell adhesion molecule-1/integrin β1
signaling in human hepatocellular carcinoma. Hepatology.
54:910–919. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shibata K, Nakayama T, Hirakawa H, Hidaka
S and Nagayasu T: Clinicopathological significance of
angiopoietin-like protein 4 expression in oesophageal squamous cell
carcinoma. J Clin Pathol. 63:1054–1058. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Minn AJ, Gupta GP, Padua D, Bos P, Nguyen
DX, Nuyten D, Kreike B, Zhang Y, Wang Y, Ishwaran H, et al: Lung
metastasis genes couple breast tumor size and metastatic spread.
Proc Natl Acad Sci USA. 104:6740–6745. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tanaka T, Imamura T, Yoneda M, Irie A, Ogi
H, Nagata M, Yoshida R, Fukuma D, Kawahara K, Shinohara M and
Nakayama H: Enhancement of active MMP release and invasive activity
of lymph node metastatic tongue cancer cells by elevated signaling
via the TNF-α-TNFR1-NF-кB pathway and a possible involvement of
angiopoietin-like 4 in lung metastasis. Int J Oncol. 49:1377–1384.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tanaka T, Nakayama H, Yoshitake Y, Irie A,
Nagata M, Kawamura K, Takamune Y, Yoshida R, Nakagawa Y, Ogi H, et
al: Selective inhibition of nuclear factor-κB by nuclear factor-κB
essential modulator-binding domain peptide suppresses the
metastasis of highly metastatic oral squamous cell carcinoma.
Cancer Sci. 103:455–463. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Koomägi R and Volm M: Expression of Fas
(CD95/APO-1) and Fas ligand in lung cancer, its prognostic and
predictive relevance. Int J Cancer. 84:239–243. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rahman MA, Dhar DK, Yamaguchi E, Maruyama
S, Sato T, Hayashi H, Ono T, Yamanoi A, Kohno H and Nagasue N:
Coexpression of inducible nitric oxide synthase and COX-2 in
hepatocellular carcinoma and surrounding liver: Possible
involvement of COX-2 in the angiogenesis of hepatitis C
virus-positive cases. Clin Cancer Res. 7:1325–1332. 2001.PubMed/NCBI
|
|
28
|
Yoneda M, Imamura R, Nitta H, Taniguchi K,
Saito F, Kikuchi K, Ogi H, Tanaka T, Katabuchi H, Nakayama H and
Imamura T: Enhancement of cancer invasion and growth via the
C5a-C5a receptor system: Implications for cancer promotion by
autoimmune diseases and association with cervical cancer invasion.
Oncol Lett. 17:913–920. 2019.PubMed/NCBI
|
|
29
|
Smart-Halajko MC, Robciuc MR, Cooper JA,
Jauhiainen M, Kumari M, Kivimaki M, Khaw KT, Boekholdt SM, Wareham
NJ, Gaunt TR, et al: The relationship between plasma
angiopoietin-like protein 4 levels, angiopoietin-like protein 4
genotype, and coronary heart disease risk. Arterioscler Thromb Vasc
Biol. 30:2277–2282. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ito Y, Oike Y, Yasunaga K, Hamada K,
Miyata K, Matsumoto S, Sugano S, Tanihara H, Masuho Y and Suda T:
Inhibition of angiogenesis and vascular leakiness by
angiopoietin-related protein 4. Cancer Res. 63:6651–6657.
2003.PubMed/NCBI
|
|
31
|
Kim SH, Park YY, Kim SW, Lee JS, Wang D
and DuBois RN: ANGPTL4 induction by prostaglandin E2 under hypoxic
conditions promotes colorectal cancer progression. Cancer Res.
71:7010–7020. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang Z, Xie J, Lin S, Li S, Huang Z, Wang
Y and Ye J: The downregulation of ANGPTL4 inhibits the migration
and proliferation of tongue squamous cell carcinoma. Arch Oral
Biol. 71:144–149. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhu P, Tan MJ, Huang RL, Tan CK, Chong HC,
Pal M, Lam CR, Boukamp P, Pan JY, Tan SH, et al: Angiopoietin-like
4 protein elevates the prosurvival intracellular
O2(−):H2O2 ratio and confers
anoikis resistance to tumors. Cancer Cell. 19:401–415. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nakayama T, Hirakawa H, Shibata K, Abe K,
Nagayasu T and Taguchi T: Expression of angiopoietin-like 4 in
human gastric cancer: ANGPTL4 promotes venous invasion. Oncol Rep.
24:599–606. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nakayama T, Hirakawa H, Shibata K, Nazneen
A, Abe K, Nagayasu T and Taguchi T: Expression of angiopoietin-like
4 (ANGPTL4) in human colorectal cancer: ANGPTL4 promotes venous
invasion and distant metastasis. Oncol Rep. 25:929–935. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yi J, Pan BZ, Xiong L and Song HZ:
Clinical significance of angiopoietin-like protein 4 expression in
tissue and serum of esophageal squamous cell carcinoma patients.
Med Oncol. 30:6802013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tanaka J, Irié T, Yamamoto G, Yasuhara R,
Isobe T, Hokazono C, Tachikawa T, Kohno Y and Mishima K: ANGPTL4
regulates the metastatic potential of oral squamous cell carcinoma.
J Oral Pathol Med. 44:126–133. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang Z, Han B, Zhang Z, Pan J and Xia H:
Expression of angiopoietin-like 4 and tenascin C but not cathepsin
C mRNA predicts prognosis of oral tongue squamous cell carcinoma.
Biomarkers. 15:39–46. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dong D, Jia L, Zhou Y, Ren L, Li J and
Zhang J: Serum level of ANGPTL4 as a potential biomarker in renal
cell carcinoma. Urol Oncol. 35:279–285. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Neto NIP, Boldarine VT, Hachul ACL, Oyama
LM, Lima JDCC, Fernandez ES, Otoch JP, de Alcântara PSM, Tokeshi F,
Seelaender MC and Oller do Nascimento CMDP: Association between
ANGPTL-4 and the proinflammatory process in cancer cachexia
patients. Oncotarget. 10:6444–6455. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Vasconcelos MG, Vasconcelos RG, Pereira de
Oliveira DH, de Moura Santos E, Pinto LP, da Silveira ÉJ and
Queiroz LM: Distribution of hypoxia-inducible factor-1α and glucose
transporter-1 in human tongue cancers. J Oral Maxillofac Surg.
73:1753–1760. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bell RB, Kademani D, Homer L, Dierks EJ
and Potter BE: Tongue cancer: Is there a difference in survival
compared with other subsites in the oral cavity? J Oral Maxillofac
Surg. 65:229–236. 2007. View Article : Google Scholar : PubMed/NCBI
|
